Pär Sparén

Pär Sparén
Photo: Ulf Sirborn

Professor

Education

1986 BA, Dept. of Sociology, Stockholm University

1996 Dr.Med.Sc., Dept. of Cancer Epidemiology, Uppsala University

Short presentation of current research

Research on human papilloma virus (HPV)

  • Occurence of HPV induced disease
  • Effects of vaccination against HPV

Research on cervical cancer

  • Occurence of cervical cancer
  • Prevention of cervical cancer by Pap smear screening
  • Hereditary and social factors in cervical cancer
  • HPV and cervical cancer

Research on psychiatric diseases and social factors in disease

  • Etiology of psychiatric disease
  • Psychiatric disease and somatic disease burden
  • Social mobility, social change and health

Research projects

Doctoral student's research project

Selected references

Magnusson PK, Sparen P, Gyllensten UB.

Genetic link to cervical tumours.

Nature 1999;400:29-30.

Edgren G, Sparen P.

Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study.

Lancet Oncol 2007;8:311-6.

Strander B, Andersson-Ellstrom A, Milsom I, Sparen P.

Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study.

Bmj 2007;335:1077.

Andrae B, Kemetli L, Sparen P, Silfverdal L, Strander B, Ryd W, Dillner J, Tornberg S.

Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.

J Natl Cancer Inst 2008;100:622-9.

Azerkan F, Zendehdel K, Tillgren P, Faxelid E, Sparen P.

Risk of cervical cancer among immigrants by age at immigration and follow-up time in Sweden, from 1968 to 2004.

Int J Cancer 2008;123:2664-70.

Arnheim DL, Tran NT, Lundholm C, Young C, Sundstrom K, Sparen P

Attitudes to HPV vaccination among parents of children aged 12-15 years - A population based survey in Sweden.

Int J Cancer. 2009 Jun 30.

Sundström K, Eloranta S, Sparén P, Arnheim Dahlström L, Gunnell A, Lindgren A, Palmgren J, Ploner A, Sanjeevi CB, Melbye M, Dillner J, Adami HO, Ylitalo N.

Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix.

Cancer Epidemiol Biomarkers Prev. 2010 Oct

Dahlström LA, Ylitalo N, Sundström K, Palmgren J, Ploner A, Eloranta S, Sanjeevi CB, Andersson S, Rohan T, Dillner J, Adami HO, Sparén P.

Prospective study of human papillomavirus and risk of cervical adenocarcinoma.

Int J Cancer. 2010 Oct 15

Sundström K, Tran TN, Lundholm C, Young C, Sparén P, Dahlström LA.

Acceptability of HPV vaccination among young adults aged 18-30 years--a population based survey in Sweden.

Vaccine. 2010 Nov 3

Ramqvist T, Du J, Lundén M, Ahrlund-Richter S, Ferreira J, Marions L, Sparén P, Andersson S, Dalianis T.

Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15-23-year-old women attending a youth health clinic in Stockholm, Sweden.

Scand J Infect Dis. 2011 Feb;43(2):115-21. Epub 2010 Oct 21

Silfverdal L, Kemetli L, Sparén P, Andrae B, Strander B, Ryd W, Dillner J, Törnberg S.

Risk of invasive cervical cancer in relation to clinical investigation and treatment after abnormal cytology: a population-based case-control study.

Int J Cancer. 2011 Sep 15

Fang F, Fall K, Sparén P, Adami HO, Valdimarsdóttir HB, Lambe M, Valdimarsdóttir U.

Risk of infection-related cancers after the loss of a child: a follow-up study in Sweden.

Cancer Res. 2011 Jan 1;71(1):116-22. Epub 2010 Nov 17

Jensen KE, Munk C, Sparen P, Tryggvadottir L, Liaw KL, Dasbach E, Nygård M, Kjaer SK.

Women's sexual behavior. Population-based study among 65,000 women from four Nordic countries before introduction of human papillomavirus vaccination.

Acta Obstet Gynecol Scand. 2011 May

Azerkan F, Sparén P, Sandin S, Tillgren P, Faxelid E, Zendehdel K.

Cervical screening participation and risk among Swedish-born and immigrant women in Sweden.

Int J Cancer. 2011 Mar 21

Olesen TB, Jensen KE, Nygård M, Tryggvadottir L, Sparén P, Hansen BT, Liaw KL, Kjær SK.

Young age at first intercourse and risk-taking behaviours--a study of nearly 65 000 women in four Nordic countries.

Eur J Public Health. 2011 May 19.

Leval A, Sundström K, Ploner A, Dahlström LA, Widmark C, Sparén P.

Assessing perceived risk and STI prevention behavior: a national population-based study with special reference to HPV.

PLoS One. 2011;6(6):e20624. Epub 2011 Jun 2.

Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M; VAESCO-GBS Case-Control Study Group.

Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.

BMJ. 2011 Jul 12;

Leval A, Herweijer E, Arnheim-Dahlström L, Walum H, Frans E, Sparén P, Simard JF.

Incidence of genital warts in sweden before and after quadrivalent human papillomavirus vaccine availability.

J Infect Dis. 2012 Sep;

Tiikkaja S, Olsson M, Malki N, Modin B, Sparén P.

Familial risk of premature cardiovascular mortality and the impact of intergenerational occupational class mobility.

Soc Sci Med. 2012 Jul 27.

Wijnans L, Lecomte C, de Vries C, Weibel D, Sammon C, Hviid A, Svanström H, Mølgaard-Nielsen D, Heijbel H, Dahlström LA, Hallgren J, Sparen P, Jennum P, Mosseveld M, Schuemie M, van der Maas N, Partinen M, Romio S, Trotta F, Santuccio C, Menna A, Plazzi G, Moghadam KK, Ferro S, Lammers GJ, Overeem S, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC.

The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.

Vaccine. 2012 Dec 16.

Arnheim-Dahlström L, Hällgren J, Weibull CE, Sparén P.

Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study.

BMJ. 2012 Dec 18;

Sundström K, Ploner A, Dahlström LA, Palmgren J, Dillner J, Adami HO, Ylitalo N, Sparén P.

Prospective Study of HPV16 Viral Load and Risk of In Situ and Invasive Squamous Cervical Cancer.

Cancer Epidemiol Biomarkers Prev. 2013 Jan;

Current doctoral students

PhD students that have already defended their thesis

More information